Specialty Pharmaceutical Company with a Focus in Pain and Addiction

Filing date Description Form Filing Group Filer View

Official notification to shareholders of matters to be brought to a vote ("Proxy")

DEF 14A
Proxy Filings
0001193125-18-211557.pdf 0001193125-18-211557.rtf 0001193125-18-211557.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0000899243-18-018489.pdf 0000899243-18-018489.rtf View HTML

A preliminary proxy statement providing notification matters to be brought to a vote

PRE 14A
Proxy Filings
0001193125-18-198130.pdf 0001193125-18-198130.rtf 0001193125-18-198130.xls View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Greenleaf Peter 0000899243-18-013845.pdf 0000899243-18-013845.rtf View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Davis Todd C 0000899243-18-013847.pdf 0000899243-18-013847.rtf View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Broadfin Capita 0000899243-18-013846.pdf 0000899243-18-013846.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-18-170236.pdf 0001193125-18-170236.rtf 0001193125-18-170236.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-18-168702.pdf 0001193125-18-168702.rtf 0001193125-18-168702.xls View HTML

An amendment to a SC 13D filing

SC 13D/A
3,4,5
0000921895-18-001770.pdf 0000921895-18-001770.rtf 0000921895-18-001770.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-18-166035.pdf 0001193125-18-166035.rtf 0001193125-18-166035.xls View HTML

Copyright Morningstar